title: Chemotherapy for Triple-Negative Breast Cancer: Is More Better?
authors.affiliation: Dana-Farber Cancer Institute, Brigham & Women's Hospital, and Harvard Medical School, Boston, MA.
authors.forename: Erica L
authors.initials: EL
authors.lastname: Mayer
authors.affiliation: Dana-Farber Cancer Institute, Brigham & Women's Hospital, and Harvard Medical School, Boston, MA hburstein@partners.org.
authors.forename: Harold J
authors.initials: HJ
authors.lastname: Burstein
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols; D001943:Breast Neoplasms; D017024:Chemotherapy, Adjuvant; D006801:Humans; D020360:Neoadjuvant Therapy; D064726:Triple Negative Breast Neoplasms